Fund Holdings — B Group, Inc.

Total Portfolio Value
$134.95M
Total Bought
$34.42M
Total Sold
$19.90M
Net Transaction
+$14.52M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
PALISADE BIO INC(PALI)04,500,000+4,500,000010,5757.84%+10,575
ADMA BIOLOGICS INC2,412,5422,457,542+45,00035,36844,82633.22%+9,458
PRAXIS PRECISION MEDICINES I(PRAX)31,50033,237+1,7371,6709,7967.26%+8,127
CELLECTIS S A(CLLS)3,281,5013,281,50109,35215,88211.77%+6,530
STRUCTURE THERAPEUTICS INC090,000+90,00006,2604.64%+6,260
SIGHT SCIENCES INC(SGHT)930,000920,000-10,0003,1997,2965.41%+4,096
TAYSHA GENE THERAPIES INC(TSHA)1,800,5561,800,55605,8889,9037.34%+4,015
SPYRE THERAPEUTICS INC(SYRE)100,000100,00001,6763,2762.43%+1,600
ASSEMBLY BIOSCIENCES INC175,706175,70604,4985,9764.43%+1,478
IOVANCE BIOTHERAPEUTICS INC(IOVA)1,500,0001,500,00003,2554,0953.03%+840
ORUKA THERAPEUTICS INC(ORKA)75,00075,00001,4422,2731.68%+831
APOGEE THERAPEUTICS INC(APGE)35,00020,000-15,0001,3911,5101.12%+119
INSMED INC(INSM)1580-158230—-23
GAMESQUARE HLDGS INC(GAME)250,0000-250,0001700—-170
AURA BIOSCIENCES INC(AURA)572,576572,57603,5393,1212.31%-418
ULTRAGENYX PHARMACEUTICAL IN(RARE)135,000135,00004,0613,1052.30%-956
NRX PHARMACEUTICALS INC(NRXP)3,000,0000-3,000,0004,4550—-4,455
ZAI LAB LTD(ZLAB)400,000400,000013,5567,0565.23%-6,500
AKERO THERAPEUTICS INC232,4460-232,44611,0370—-11,037
Page 1 of 1
B Group, Inc. — 13F Holdings — Q4 2025 | TickerTrail